Loading...
Vernakalent, CV death in cancer patients, dapagliflozin, and sacubitril/valsartan are the topics Dr. John Mandrola discusses in this week's podcast.
John Mandrola
Host
Dr. John Mandrola
Guest
No transcript available for this episode.
This Week in Cardiology